T-cell prolymphocytic leukemia

T-cell prolymphocytic leukemia (T-PLL) is a rare and aggressive type of leukemia that affects the T cells, a type of white blood cell that plays a crucial role in the immune system. It is characterized by the overproduction of immature T cells, known as prolymphocytes, in the bloodstream.

Symptoms

The symptoms of T-PLL can vary, but often include fatigue, fever, night sweats, and unexplained weight loss. Other symptoms may include swollen lymph nodes, an enlarged spleen, and skin rashes.

Causes

The exact cause of T-PLL is unknown, but it is believed to be related to genetic mutations. Some studies have suggested a link between T-PLL and exposure to certain chemicals or radiation, but more research is needed to confirm these findings.

Diagnosis

T-PLL is typically diagnosed through a combination of blood tests, bone marrow biopsy, and genetic testing. The presence of an unusually high number of prolymphocytes in the blood or bone marrow is a key indicator of the disease.

Treatment

Treatment for T-PLL typically involves chemotherapy, immunotherapy, or a combination of both. In some cases, a stem cell transplant may be considered.

Prognosis

The prognosis for T-PLL is generally poor, with a median survival time of less than two years. However, some patients may respond well to treatment and achieve long-term remission.

See also

• Leukemia
• T cell
• Chemotherapy
• Immunotherapy
• Stem cell transplant

NIH genetic and rare disease info

• NIH info on T-cell prolymphocytic leukemia

T-cell prolymphocytic leukemia is a rare disease.

This article is a medical stub. You can help WikiMD by expanding it!
Most recent articles Ongoing trials	Wikipedia

   This article is a medical stub. You can help WikiMD by expanding it!